Exploring Risks of Human Challenge Trials for COVID-19

David Manheim, Witold Więcek, Virginia Schmit, Josh Morrison, 1Day Sooner Research Team
doi: https://doi.org/10.1101/2020.11.19.20234658

Article Information

doi 
https://doi.org/10.1101/2020.11.19.20234658
History 
  • March 12, 2021.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. David Manheim, PhD*,1,2,#,
  2. Witold Więcek, PhD*,1,3,
  3. Virginia Schmit, PhD1,
  4. Josh Morrison1,
  5. 1Day Sooner Research Team
  1. 11DaySooner, Delaware, United States
  2. 2Health and Risk Communication Research Center, University of Haifa, School of Public Health, Haifa, Israel
  3. 3WAW Statistical Consulting Ltd, United Kingdom
  1. ↵#Correspondence David Manheim, PhD, Email: media{at}1daysooner.org

  1. ↵* Equally Contributing Authors

Back to top
Posted March 12, 2021.
Download PDF
Data/Code
Email
Exploring Risks of Human Challenge Trials for COVID-19
David Manheim, Witold Więcek, Virginia Schmit, Josh Morrison, 1Day Sooner Research Team
medRxiv 2020.11.19.20234658; doi: https://doi.org/10.1101/2020.11.19.20234658
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area